17 January 2017
News and Views
Links and Services
This week's issue of the New England Journal of Medicine evaluates the use of ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection.
Effective treatment for hepatitis C virus (HCV) genotype 1 infection in patients who have not had
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors